Physician

Arin L Isenstein, M.D.

According to 2025 Medicare claims, Arin Isenstein, M.D. (NPI: 1871794032) practices dermatology in the Burlington, NC market, with the plurality of this provider's patient population coming from Alamance, NC. This provider's primary affiliated billing organization is ALAMANCE DERMATOLOGY, P.A. (NPI: 1346537180; TIN: 452150951) and primary practice location at 27217-3100. Isenstein is affiliated with the Triad HealthCare Network, LLC. (ACO ID: D0209), participating under the REACH model.

Isenstein's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 442 traditional Medicare patients, billed 1,898 HCPCS/CPT codes, and received $92,283 in Medicare payments. The top billing code was 17110 (Destruction of skin growth, 1-14 growths). Part D data shows 733 prescription claims across 303 beneficiaries totaling $164,803 in drug costs, led by Humira(Cf) Pen (Adalimumab). Open Payments data shows 39 records totaling $877. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $58,205 to $164,803. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$57K$114K2015 Medicare payment: $113,807 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $109,386 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $100,652 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $97,560 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $96,731 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $85,042 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $96,559 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $90,853 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $104,169 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $92,283 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20154292,110$113,807
20164852,023$109,386
20175102,057$100,652
20185042,042$97,560
20195111,932$96,731
20204541,764$85,042
20215031,927$96,559
20225091,874$90,853
20234892,072$104,169
20244421,898$92,283

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$186K$372K2015 Drug cost: $58,205 (USD; Tot_Drug_Cst)2016 Drug cost: $48,663 (USD; Tot_Drug_Cst)2017 Drug cost: $52,511 (USD; Tot_Drug_Cst)2018 Drug cost: $70,284 (USD; Tot_Drug_Cst)2019 Drug cost: $200,018 (USD; Tot_Drug_Cst)2020 Drug cost: $126,806 (USD; Tot_Drug_Cst)2021 Drug cost: $252,237 (USD; Tot_Drug_Cst)2022 Drug cost: $371,901 (USD; Tot_Drug_Cst)2023 Drug cost: $249,457 (USD; Tot_Drug_Cst)2024 Drug cost: $164,803 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015251528$58,205
2016279566$48,663
2017312666$52,511
2018297653$70,284
2019300682$200,018
2020284630$126,806
2021265657$252,237
2022260614$371,901
2023301653$249,457
2024303733$164,803

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
17110Destruction of skin growth, 1-14 growths6270$75
11102Biopsy of related skin growth, first growth108139$55
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more393475$55
17000Destruction of precancer skin growth, 1 growth152181$31
17003Destruction of precancer skin growth, 2-14 growths112567$4

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Humira(Cf) PenAdalimumab13364$88,194
Clobetasol PropionateClobetasol Propionate892,455$1,857
MetronidazoleMetronidazole32879$1,540
Doxycycline HyclateDoxycycline Hyclate361,297$795
TretinoinTretinoin16407$731

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.39$877Regeneron Healthcare Solutions, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Arin L. Isenstein, M.D.?

Tedicare shows public-source Medicare data for Arin L. Isenstein, M.D. (NPI 1871794032), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Arin L. Isenstein, M.D. have ACO affiliation data?

Arin L. Isenstein, M.D. is shown with ACO affiliation data for Triad HealthCare Network, LLC. (REACH, ACO ID D0209).

What billing organization is linked to Arin L. Isenstein, M.D.?

Arin L. Isenstein, M.D. is linked to ALAMANCE DERMATOLOGY, P.A. (billing NPI 1346537180) in the available physician profile data.

Does Arin L. Isenstein, M.D. have Open Payments data?

Arin L. Isenstein, M.D. has 39 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.